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Vulnerability of neuronal cells to environmental
stress contributes to pathogenesis of neurodegener-
ative disorders. For instance, neurons are relatively
susceptible to ischemic stress, while other cell types,
such as astrocytes, display a comparatively resistant
phenotype. Astrocytes not only survive under hypox-
ic/ischemic conditions, but elaborate neurotrophic
factors (1, 2). We have cloned an endoplasmic reticu-
lum chaperone, 150-kDa oxygen-regulated protein
(ORP150), which is abundantly produced by astro-
cytes subject to ischemic stress (3, 4). Furthermore,
suppression of ORP150 in human cells leads to 
the loss of their viability in response to oxygen 
deprivation (5).
Neurotoxicity caused by the excitatory amino acid,
such as glutamate, contributes to pathogenesis in the
central nervous system, including neurodegenerative
disease (6), brain ischemia (7–9), and traumatic dam-
age (10). The cytotoxic effect by excitatory amino acid,
which mainly affects neurons (11), suggests that exci-
tatory amino acid acts as a unique environmental stress
to neurons and, at the same time, implies that intracel-
lular tools may function in neurons to withstand cel-
lular metabolic crisis.
Studies using kainate, an excitatory amino acid
extracted from seaweed, have provided major contri-
butions to the understanding of neuronal cell death
caused by excitotoxicity. CA3 neurons, for instance,
demonstrate marked vulnerability to the local admin-
istration of kainate, which is represented by a massive
degeneration of neurons and recurrent seizures. Thus,
local injection of kainate to the hippocampus, which
causes the sustained release of glutamate, has been
used as a model to analyze the brain damage caused by
excitatory amino acid (12).
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A series of events initiated by glutamate-receptor interaction perturbs cellular homeostasis resulting
in elevation of intracellular free calcium and cell death. Cells subject to such environmental change
express stress proteins, which contribute importantly to maintenance of metabolic homeostasis and
viability. We show that an inducible chaperone present in endoplasmic reticulum (ER), the 150-kDa
oxygen-regulated protein (ORP150), is expressed both in the human brain after seizure attack and in
mouse hippocampus after kainate administration. Using mice heterozygous for ORP150 deficiency,
exposure to excitatory stimuli caused hippocampal neurons to display exaggerated elevation of
cytosolic calcium accompanied by activation of µ-calpain and cathepsin B, as well as increased vul-
nerability to glutamate-induced cell death in vitro and decreased survival to kainate in vivo. In con-
trast, targeted neuronal overexpression of ORP150 suppressed each of these events and enhanced
neuronal and animal survival in parallel with diminished seizure intensity. Studies using cultured
hippocampal neurons showed that ORP150 regulates cytosolic free calcium and activation of prote-
olytic pathways causing cell death in neurons subject to excitatory stress. Our data underscore a pos-
sible role for ER stress in glutamate toxicity and pinpoint a key ER chaperone, ORP150, which con-
tributes to the stress response critical for neuronal survival.
J. Clin. Invest. 108:1439–1450 (2001). DOI:10.1172/JCI200112978.
Here we demonstrate that the neurons express
ORP150 in response to glutamate, a major agent in
which excitatory neuronal stimuli exist. Furthermore,
mice with a truncated mutation of ORP150 showed an
enhanced vulnerability to the intraventricular admin-
istration of kainate, whereas TG mice overexpressing
ORP150 in neurons exhibited an improved viability in
the hippocampus. These data suggest that neuronal
ORP150 contributes centrally to metabolic homeosta-
sis and survival of vulnerable neurons both in vitro and
in vivo in response to excitatory stimuli.
Methods
Animals. To generate mice deficient in ORP150, a tar-
geting vector was constructed consisting of a 15.1-kb
SspI/SacI restriction fragment from the 129Sv mouse
ORP150 gene (Figure 1) in which a PGK-neoR cassette
replaced the NotI/SspI fragment (2.3 kb) that over-
laps exon 7 of ORP150. Transfection and selection
procedures using W9.5 embryonic stem cells were per-
formed as described (13). Southern blotting of
genomic DNA following digestion with KpnI (for the
5′ probe), SphI (for the 5′probe), and SacI/XhoI, iden-
tified positive clones (2 of 213) (for the 3′ probe). Two
clones were injected into 129Sv blastocytes. Germline
transmission of the ORP150 mutant gene was
achieved, and mice were backcrossed into the
C57BL/6 strain for ten generations. Genotype assign-
ment was determined by Southern blot analysis.
Expression of ORP150 in a range of organs was deter-
mined by immunoblotting of tissue extracts using
ORP150 Ab (3 µg/ml).
Transgenic mice with expression of wild-type
ORP150 targeted to neurons using the PDGF B-chain
promoter (14) were reported previously (15). After the
sixth generation, offspring that carried the transgene
were identified by Southern blot analysis of genomic
DNA extracted from tails.
Kainate administration. Kainate (0–0.4 µg in a volume
of 0.5 µl; Tocris Cookson Ltd., Bristol, United King-
dom) was injected unilaterally into the dorsal hip-
pocampi of anesthetized male mice (12 weeks old) as
described by Guo et al. (6). Some animals were sacri-
ficed 24 hours later for biochemical analysis. The oth-
ers were perfused with fixative 4–24 hours later for his-
tochemistry. For behavioral studies, kainate (0–20
mg/kg) was administered intraperitoneally to mice (12
weeks old) under brief ether anesthesia.
Behavioral studies. The mice were monitored continu-
ously for 2 hours to evaluate the onset and extent of
seizures as described (16). Seizure severity was scored
according to the following arbitrary scale: 0, no seizure;
1, one seizure; 2, two to five seizures; 3, five to ten
seizures; 4, more than ten seizures (or severe tonic
chronic seizure); and, 5, death within 2 hours. The
seizure index was calculated by averaging the points of
seizure severity in a given group.
Histochemistry. Human brain samples were obtained
from legal pathology specimens under the auspices
of an approved institutional review board protocol.
The hippocampal area was cut into 5-µm paraffin
sections. In the murine model, animals were perfused
with 4% paraformaldehyde under deep anesthesia,
and the brains were cut coronally on a cryostat in 14-
µm thickness. Sections were processed for cresyl vio-
let staining or immunohistochemistry using either
rabbit anti-human ORP150 (5 µg/ml) (3–5), mono-
clonal mouse anti-MAP2 (Sigma Chemical Co., St.
Louis, Missouri, USA; 1:1,000 dilution), goat anti-
GFAP (1:100 dilution; Santa Cruz Biotechnology
Inc., Santa Cruz, California, USA), goat anti–Glu-R6
(1:100 dilution; Santa Cruz Biotechnology Inc.), rab-
bit anti–GRP78 (1:500 dilution; StressGen Biotec-
nologies Corp., Victoria, British Columbia, Canada),
or rabbit anti–GRP94 (1:500 dilution; StressGen
Biotecnologies Corp.).
Assessment for neuronal cell death in vivo. Coronal hip-
pocampal sections were evaluated by Nissl staining (6)
and immunostaining with anti–MAP2 Ab (0.3 µg/ml)
(15). Nissl-positive neurons and neuronal processes
positive for MAP2 antigen were counted in hippocam-
pal lesions, CA1, CA2/3, and CA4/hillus. Counts were
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Figure 1
Generation of heterozygous ORP150-deficient mice. Structure of ORP150 genomic DNA depicting the long and short arms of the targeting
vector is shown at the top, and the targeting vector itself is shown in the middle. After homologous recombination, the resulting mutant (func-
tionally “null”) allele, in which a 1.2-kb deletion was made (including all exons except 2, 3, 11, 14, 25, and 26), is shown at the bottom.
made in three fields (×40) by two experimenters with-
out knowledge of experimental protocol.
Cell culture of hippocampal neurons and cortical astroglia.
Cultured hippocampal neurons were prepared from
newborn C57BLKS/J mice within 1 day of birth, and
their genotype was determined by PCR, as described
(17). In brief, hippocampi were separated and incubat-
ed in Ca2+- and Mg2+- free HBBS containing papain
(0.2%). Cells were plated in plastic wells precoated with
poly-lysine (10 µg/ml; Sigma Chemical Co.). Cultures
were then maintained for 3 days in MEM supplement-
ed with heat-inactivated FCS (10%), glucose (30 mM),
L-glutamine (2 mM), pyruvate (1 mM), KCl (20 mM),
sodium bicarbonate (10 mM), and HEPES (1 mM; pH
7.2), followed by the incubation for additional 2 days in
the presence of cytosine β-D-arabiofuranoside (Ara-C)
(10 µg/ml; Sigma Chemical Co.). Cultures were washed
three times with PBS, and medium was replaced with
Locke’s buffer containing NaCl (154 mM), KCl (5.6
mM), CaCl2 (2.3 mM), MgCl2 (1.0 mM), NaHCO3 (3.6
mM), glucose (5 mM), and HEPES (5 mM; pH 7.2)
before the experiments.
Astroglia were also prepared from cerebral cortex as
described previously (2). Cells digested from the cere-
bral cortex, as above, were plated in T125 flasks and
maintained in DMEM supplemented with FCS (8%) for
10 days. Cultures were then treated with Ara-C (10
µg/ml) for 48 hours, replanted, and used for experi-
ments after achieving confluence.
Assessment for cell death in vitro. Glutamate (Sigma
Chemical Co.) was prepared in Locke’s buffer. Cell via-
bility was assessed by dye exclusion or morphological
criteria (6). For the latter, a neuron with intact neurites
and cell body that was smooth and round-to-oval in
shape was considered viable. A neuron with fragment-
ed neurites and a cell body that was shrunken and
rough in appearance was considered nonviable. Where
indicated, neuronal cells were also cultured in the pres-
ence of either N-methyl-D-aspartate (NMDA), buthio-
nine sulfoximine (BSO), or MK-801 (all reagents were
purchased from Sigma Chemical Co.).
Western blot and ELISA analyses. Levels of ORP150
antigen in cell or tissue extracts was determined
semiquantitatively by immunoblotting as described
(18). Tissue extracts were prepared from cultured
cells or murine tissue in PBS containing NP-40 (1%).
Proteins were separated by SDS-PAGE and trans-
ferred to PVDF paper, followed by incubation with
anti-human ORP150 Ab (1 µg/ml). Where indicated,
Western blot analysis using anti-KDEL mAb (0.2
µg/ml; StressGen Biotecnologies Corp.) assessed lev-
els of GRP78 and GRP94 (5).
For quantitative analysis of hippocampal ORP150
content, ELISA was performed as described previ-
ously (19). In brief, hippocampal homogenates (1
mg/ml; 0.1 ml) were coated on Nunc Maxi-Sorp
plates (Nalge Nunc International, Rochester, New
York, USA). Wells were incubated with anti-ORP150
IgG (3 µg/ml; 0.1 ml) for 2 hours at 37°C, washed
three times, and incubated with peroxidase-labeled
goat anti-rabbit IgG (1:3,000 dilution, 0.1 ml; Sigma
Chemical Co.) followed by the development with o-
phenylenediamine dihydrochloride (ODP; Sigma
Chemical Co.). ORP150 equivalent values were deter-
mined using a standard curve prepared with human
recombinant ORP150 (4). In each case, total protein
content in the mixture was determined by the
method of Lowry (20).
Measurement of intracellular calcium and GSH level. Mea-
surement of intracellular calcium in cultured neurons
was performed as described (21). Neuron-rich hip-
pocampal cultures (about 5 × 104 cells/well) planted in
an eight-well chamber slide (Lab-Tek; Nalge Nunc
International, Naperville, Illinois, USA) were washed
three times in Locke’s buffer and incubated with 25 µl
of fluo-3/AM (final 20 µM; Molecular Probes Inc.,
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Figure 2
Expression of ORP150 in human brain: effect of excitatory and nutritional stress. The hippocampal area was prepared from autopsy sam-
ples of patients who died with uncontrolled status epilepticus, (a–d) 46-year-old female, and hemorrhagic shock, (e–h) 45-year-old
female. In each case, the hippocampal area was stained with cresyl violet (a and e) (×400). Sections adjacent to a and e were stained
with either anti-human ORP150 (b and f) (×400) or GFAP Ab (c and g) (×400). Images of ORP150 (b and f) and GFAP (c and g) are dig-
itally overlapped in d and h.
Eugene, Oregon, USA) dissolved in HEPES (20 µM, pH
7.4) buffered saline at 20°C for 15 minutes. After
washed HEPES-buffered saline, cells were subjected to
[Ca++]i imaging with Argus-20 fluorescent imaging
processor (Hamamatsu Photonics, Hamamatsu City,
Japan), with excitation wavelength of 485nm and emis-
sion wavelength of 505nm. Regions of interest (ROIs)
were determined by morphological examination of
neurons, and calibration was done with cells incubat-
ed with the ionophore A-23187 (10 µM; Sigma Chem-
ical Co.) to obtain Fmax and with CuCl2 (2 mM) and 
A-23187 (10 µM) dissolved in NaCl (0.9%) to obtain
Fmin. Cytosolic free Ca++ was calculated with the fol-
lowing formula: [Ca++]i = Kd (F – Fmin)/(Fmax – F), where
F is the fluorescence at intermediate calcium level, Kd is
the ion dissociation constant, Fmax is the fluorescence
of the calcium-saturated indicator, and Fmin is the flu-
orescence intensity of the indicator in the absence of
calcium. Cellular glutathione level was determined
using a commercially available kit (Cayman Chemical,
Ann Arbor, Michigan, USA) according to the manufac-
turer’s manual, as described previously (22).
Activation of calpain/cathepsin B activity. Activation of
Ca++-dependent proteinase was assessed as described
(23). To assess activation of calpain, protein extracts were
prepared from either cultured neurons, 6 hours after
glutamate treatment, or murine hippocampal lesions, 8
hours after administration of kainate. Proteins were
extracted in PBS containing NP-40 (1%) and were sepa-
rated by SDS-PAGE (10%), followed by the Western blot
with anti–human µ-calpain Ab (×400; Santa Cruz
Biotechnology Inc). To evaluate cathepsin B activity (24),
hippocampal homogenate in PBS (10 µl) was incubated
in sodium acetate buffer (2.5 µl, 400 mM; pH 5.5) con-
taining cysteine (8 mM) at 37°C for 5 minutes. Synthet-
ic peptide substrate, Z-Arg-Arg-AMC (1 mM; Peptide
Institute Inc., Osaka, Japan), was added, and the mixture
was incubated for a further 5 minutes at 37°C, followed
by termination in the presence of SDS (5% final concen-
tration) and dilution in Tris-HCl (2 ml; 100 mM).
Release of 7-amino-4-methylcoumarin (AMC) was
measured by fluorescence spectrophotometry using
wavelengths of 370nm (excitation) and 460nm (emission).
Data analysis. Statistical analysis was performed by
ANOVA followed by multiple comparison analysis
using Newman-Kuehls equation. Where indicated, data
were analyzed by two-way ANOVA followed by the mul-
tiple contrast analysis. For nonparametric data, either
Kruskal-Wallis analysis or χ2 analysis was applied.
Results
Expression of ORP150 in hippocampal neurons is strongly asso-
ciated with excitatory neuronal stress. Immunoreactive
ORP150 was detected in hippocampal neurons from a
patient who died with uncontrolled status epilepticus
(Figure 2b; Figure 2a shows cresyl violet staining for ori-
entation). In these patients, ORP150 was not expressed
in measurable amounts in astrocytes, as demonstrated
by confocal microscopy with Ab to GFAP (Figure 2, c
and d). In contrast, neuronal staining was not observed
in a patient with a history of status epilepticus con-
trolled with anticonvulsants who expired due to an
overdose of these drugs (data not shown). In a patient
who died due to hemorrhagic shock (Figure 2, e–h),
ORP150 expression was observed in neurons (Figure 2,
e and f) as well as astrocytes (Figure 2, f–h).
These data suggested an association of ORP150
expression with cell stress and emphasized the possi-
ble relevance of neuronal ORP150 to excitotoxicity.
Consistent with this concept, intrahippocampal
administration of kainate-induced expression of
ORP150 in the hippocampus, especially in CA3 (Fig-
ure 3, a–e). Furthermore, cultured hippocampal neu-
rons (> 90% neurons by MAP2 staining) exposed to
glutamate demonstrated transient expression of
ORP150 at 8–12 hours (Figure 3f), which occurred in
a dose-dependent manner at higher glutamate con-
centrations (Figure 3g; 5–20 µM) and was followed by
cell death at 24 hours (Figure 3k). Note that levels of
ORP150 in cultured astroglia remained low through-
out exposure to glutamate (Figure 3, f–i). We fail to
confirm the induction of ORP150, even in the experi-
ments where larger amount of protein extract (5 µg)
was loaded or higher concentration of glutamate
(0.2–1 mM), which can even cause cell death in astro-
cytes (ref. 25; data not shown), was used, whereas
hypoxia stimulated the expression of endoplasmic
reticulum chaperones (ER chaperones) in both cell
types (lane “Hypoxia,” Figure 3, g and j). Furthermore,
cell viability was not changed under these conditions
(Figure 3, f and g), and these data suggest that induc-
tion of ORP150 detected in this set of experiments
mainly reflect the response in neurons.
To further characterize this response in neurons, addi-
tional experiments were performed, where similar
results were obtained after the exposure to NMDA, a
prototypic agonist for glutamate receptor, instead of
glutamate (Figure 3, j and l), suggesting that the induc-
tion of ORP150 and cell death caused by the exposure
of glutamate is mediated by NMDA receptor. Consis-
tently, pretreatment of cultures with MK-801 (1 µM; ref.
26) suppressed glutamate-mediated ORP150 induction
(Figure 3j, lanes glutamate and glutamate + MK-801),
as well as the neuronal cell death (Figure 3m). Further-
more, densitometric analysis revealed that induction of
ORP150 is significantly larger compared with those of
other ER chaperones (GRP78 and GRP94; Figure 3, h
and i). These observations underscored the likelihood
of a relationship between ORP150 and the neuronal
response to excitatory stimuli.
Neuroprotective properties of ORP150: kainate-induced
cytotoxicity. The role of ORP150 in excitotoxicity was
explored using mice heterozygous for ORP150 defi-
ciency, and transgenic animals with targeted expres-
sion of ORP150 in neurons. Although a predicted
gene product encoding the first 226 amino acids
would have been expected to result from the mutated
ORP150 gene, immunoblotting using several Ab’s to
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Figure 3
Expression of ORP150 in mouse hippocampus and cultured neurons in response to excitatory stress. (a–e) After the intrahippocampal admin-
istration of vehicle alone for 12 hours (a) or kainate (b–e), corresponding to 0.3 µg in 0.5 µl of PBS, the hippocampus was stained with
anti–human ORP150 Ab; (a–d) ×40, (e) ×80. (f–j) Cultured neurons or astrocytes were exposed to either (f) glutamate (10 µM) for 0–24
hours, (g) glutamate (0–50 µM) for 8 hours, or exposed to hypoxia (12 hours for neuron and 24 hours for astrocytes; lane “Hypoxia”). Pro-
tein extracts (≈10 µg in neurons and 2 µg for astrocytes) were subjected to Western blot analysis with either anti-human ORP150 Ab or anti-
KDEL Ab. Induction was quantified by densitometric analysis of the gel and expressed as fold increase of peak density against nonstimulat-
ed level. (h) Time course corresponding to f. (i) Dose response corresponding to g. (n = 4, mean ± SD is shown). *P < 0.01 by multiple
comparison analysis, followed by one-way ANOVA. (j) Neurons were treated with NMDA (50 µM) for 0–24 hours or for 8 hours with NMDA
(0–50 µM). Cultures were also treated with glutamate (10 µM) for 8 hours either in the absence or presence of MK-801, followed by West-
ern blot analysis. (k–m) Viability of astrocytes (open bars) or neurons (filled bars) 24 hours after the addition of either glutamate (k) or
NMDA (l) is shown (n = 8, mean ± SD). Viability were also assessed in neurons cultured with glutamate (50 µM) in the presence of MK-801
(0–1 µM) for 24 hours (m). **P < 0.01 by multiple contrast analysis, followed by two-way ANOVA, and *P < 0.01 by multiple comparison
analysis, followed by one-way ANOVA, respectively.
ORP150 reactive this N-terminal region did not
demonstrate a product other than full-length
ORP150 (molecular weight = 150 kDa) in tissue
extracts from heterozygous ORP150-deficient mice
(data not shown). Thus, the truncated gene is termed
a null allele, and the heterozygous mice are referred to
as ORP150–/+. When ORP150–/+ mice were mated, no
viable homozygous null mice were produced over 100
matings, indicating that deletion of ORP150 results
in embryonic lethality (further characterization of
this phenotype is the subject of work in progress). For
this reason, heterozygous ORP150-deficient mice
were employed for subsequent studies; decreased lev-
els of ORP150 antigen by about 30–60% were
observed in ORP150–/+ mice, compared with
ORP150+/+ animals (nontransgenic littermate con-
trols), in a range of organs based on ELISA (Figure
4a). This is especially evident in the spleen and liver,
organs with the highest baseline levels of ORP150.
Genetically manipulated mice were also made in
which expression of the human ORP150 cDNA (3 kb)
was placed under control of the PDGF B-chain pro-
moter, resulting in increased neuronal ORP150
(termed Tg PD-ORP150 mice; ref. 15). Several
founders were identified by Southern blot analysis
(not shown). Northern analysis of the brain demon-
strated increased ORP150 transcripts (not shown),
and ELISA demonstrated about fivefold elevated lev-
els of ORP150 antigen in the brain of transgenic ani-
mals, compared with that of nontransgenic controls,
whereas the ORP150 antigen obtained from other
organs showed no significant difference (Figure 4a).
The power of these genetic approaches for manipu-
lating neuronal ORP150 expression is illustrated by
parallel immunohistochemical analysis of hip-
pocampi from the three different types of mice with
Ab to ORP150; lowest levels are observed in ORP150–/+
(Figure 4b), intermediate levels in ORP150+/+ (Figure
4c), and highest levels in Tg PD-ORP150 (Figure 4,
d–e). ELISA of ORP150 antigen in the hippocampus
(brain homogenate sample) revealed that ORP150
remained suppressed in ORP150–/+ mice even after
hippocampal administration of kainate (Figure 4f). In
contrast, ORP150+/+ control mice receiving a low dose
of kainate (0.1 µg injected directly into the hip-
pocampus) displayed increased ORP150 by about
threefold, whereas a high dose of kainate (0.4 µg) sup-
pressed ORP150 (Figure 4f; this is analogous to our in




and transgenic mice. (a and f)
ELISA analysis of ORP150 was
performed in protein extracts
prepared from systemic organs
(a) or hippocampus 12 hours
after the administration of
kainate (f) (0–0.4 µg) of either
heterozygous ORP150-defi-
cient mice (ORP150–/+), wild-
type littermates (ORP150+/+),
or Tg PD-ORP150 mice
(Transgenic). The mean ± SD
is shown (n = 6). (b–e) Base-
line expression of ORP150 was
assessed by immunohisto-
chemical analysis using anti-
ORP150 Ab; (b–d) ×80, and
(e) ×400. (g) Expression of
Glu-R6 assessed immunohis-
tochemically in each type of
mice (×200). Expression of
GRP78 (h) and GRP94 (i) was
assessed by immunohisto-
chemical analysis using specif-
ic Ab’s 12 hours after the
intrahippocampal administra-
tion of kainate (0.1 µg; ×40).
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Figure 5
Role of ORP150 in the neuronal response to kainate. Either Nissl (a–k) or immunostaining (l–t) of MAP2 was performed in each mouse
type 12 hours after the intraventricular administration of kainate (0–0.4 µg). (a–i) and (l–t) ×400. Quantitative analysis of neuronal via-
bility from CA-1 and CA-3 are added (j and k and u and v) in each case. Mean ± SD is shown (n = 8). Asterisks indicate P < 0.01 by mul-
tiple contrast analysis compared with wild-type mice. (w–y) Survival 24 hours after intraperitoneal administration of kainate (w). Occur-
rence of seizures (x) and seizure index (y) 4 hours after kainate were assessed as described. Mean ± SD is shown (n = 6). # symbols indicate
P < 0.01 by χ2 analysis compared with wild type mice. Asterisks indicate P < 0.01 by multiple contrast analysis following Kruskal-Wallis
analysis compared with wild-type mice.
vitro results with glutamate in Figure 3g). The latter
might be due to the neuronal degeneration occurring
in the hippocampus consequent to kainate treatment
(see below). Hippocampal administration of kainate
was without effect on ORP150 expression in Tg 
PD-ORP150 mice in this brain subregion (Figure 4f).
It is important to note that expression of Glu-R6, a
subunit of kainate receptor that contributes to
kainate-mediated cell death (16), was unchanged in
these groups of mice (Figure 4g). Expression of GRP78
and GRP94 were also not affected by changes in the
level of ORP150, even after the administration of
kainate (Figure 4, h and i). Kainate did induce expres-
sion of GRP78 and GRP94 (compare with and with-
out kainate in Figure 4, h and i).
Using the three different types of mice, with respect
to neuronal expression of ORP150, neuronal vulnera-
bility to hippocampal administration of kainate was
studied. Nissl staining of the hippocampal region
revealed enhanced neuronal cell death caused by exci-
totoxicity in ORP150–/+ mice (Figure 5, a–c), compared
with ORP150+/+ (Figure 5, d–f), whereas Tg 
PD-ORP150 mice were more resistant (Figure 5, g–i).
Quantitative analysis of Nissl-positive cells, performed
separately in CA1 and CA3, demonstrated neuronal
damage consequent with intrahippocampal adminis-
tration of kainate most apparently in CA3, especially in
ORP150–/+ mice compared with Tg PD-ORP150 ani-
mals (Figure 5, j and k). ORP150+/+ controls showed an
intermediate level of neurotoxicity (Figure 5, d, f, j, and
k). Immunostaining with Ab to MAP2 confirmed this
pattern of neuronal degeneration following hip-
pocampal injection of kainate with the strongest reduc-
tion in immunoreactivity in the CA3 region of
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Figure 6
Role of ORP150 in stress response to glutamate in vitro. (a–d) Cultured hippocampal neurons from ORP150–/+, nontransgenic littermates
(ORP150+/+), or Tg PD-ORP150 mice (Transgenic) were exposed to the indicated concentration of either glutamate (a) or NMDA (c) for 24
hours or exposed to (b) glutamate (20 µM) or (d) NMDA (50 µM) for the indicated time. Percentage of viable neurons was determined as
described in text. The mean ± SD is shown (n = 8). Asterisks indicate P < 0.01 compared with ORP150+/+ mice by multiple contrast analysis.
(e–h) Hippocampal neurons were prepared from genetically manipulated mice, as above, and exposed to either (e)glutamate (10 µM) or
(f–h) NMDA (50 µM). Cytosolic-free Ca++ was measured by fluorescent technique in ten representative neuron bodies, which were mor-
phologically identified as described in the text. (e and f) Time course, mean of ten replicate experiments. (g) Peak and plateau (mean ± SD
and n = 6) are shown. Ca++ was measured at the peak of NMDA-induced Ca++ (peak) and 5 minutes after the peak (plateau). *P < 0.05 and
**P < 0.01 compared with ORP150–/+ neurons by multiple comparison analysis followed by one-way ANOVA. (h) Typical Ca++ image
obtained at the peak by each culture is shown (Ca++ image, left panels; phase image, right panels; ×200 in each case).
ORP150–/+ animals versus greatest retention of
immunoreactivity in Tg PD-ORP150 mice (Figure 5,
l–t). Quantitative analysis in the density of neurites in
hippocampal area showed the same tendency (Figure 5,
u–v). These differences in neuronal vulnerability to
kainate, as evaluated by neuropathologic criteria, par-
alleled the results of functional studies after intraperi-
toneal administration of kainate; increased levels of
ORP150 in Tg PD-ORP150 animals were associated
with increased survival (Figure 5w) and less severe
seizures (Figure 5, x and y). Wild-type mice (ORP150+/+)
with intermediate levels of ORP150, between
ORP150–/+ and Tg PD-ORP150, also showed interme-
diate survival and seizure intensity, compared with
these two other groups of mice (Figure 5, w–y).
Mechanisms underlying the protective function of ORP150
in neurons. Experiments were performed with hip-
pocampal neurons isolated from ORP150–/+, non-
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Figure 7
Activation of Ca++-dependent proteinase in hippocampus. (a–b) Cultured neurons were treated with glutamate (20 µM) for 6 hours in the
absence or presence of ZLLLal (10 µM). Protein extracts were then subjected to SDS-PAGE/immunoblotting using anti–µ-calpain Ab (a).
Cathepsin B activity was measured by hydrolysis of peptide substrate in the medium. Mean ± SD is shown (n = 4). **P < 0.01 by multiple
contrast analysis compared with ORP150–/+ mice (b). (c–d) Activation of µ-calpain, monitored by immunoblotting, was assessed in tissue
extract of the hippocampal region 8 hours after the administration of kainate (c). Upper and lower arrowheads indicate the preactivated
and activated forms of µ-calpain, respectively. Migration of molecular weight markers (in kilodaltons) is indicated on the far right side of
the gel. Cathepsin B activity was measured by the hydrolysis of synthetic peptide substrate in the hippocampal region 8 hours after the admin-
istration of kainate (d). Mean ± SD is shown (n = 4). *P < 0.05 and **P < 0.01 by multiple contrast analysis compared with wild-type
(ORP150+/+) mice. (e–f) Cultured neurons from C57BL6/J mice were exposed to the indicated concentration of BSO for up to 36 hours. Pro-
tein extracts (10 µg) were subjected to Western blot analysis with anti-human ORP150 (e). Neuron cultures were also exposed to hypoxia
(12 hours), followed by Western blot analysis (lane, “Hypoxia”). Cultured hippocampal neurons from ORP150–/+, ORP150+/+, or Tg 
PD-ORP150 mice were exposed to the indicated concentration of BSO, and percentage of neuron viability was determined 24 and 36 hours
after the exposure to BSO (f). The mean ± SD is shown (n = 8).
transgenic littermate controls (ORP150+/+), and Tg
PD-ORP150 mice to dissect mechanisms underlying
ORP150-mediated neuroprotection in response to
kainate. First, neuronal cell death was monitored in
cultures exposed to a range of glutamate concentra-
tions for 24 hours. Cell viability was best maintained
in cultures from Tg PD-ORP150 mice, whereas cells
from ORP150–/+ animals were most vulnerable to glu-
tamate-induced cytotoxicity (Figure 6, a and b).
Experiments performed in neuron cultures exposed
to NMDA showed similar results in these three types,
as observed with glutamate (Figure 6, c and d). Sec-
ond, intracellular Ca++ was measured in neuron cul-
tures. [Ca++]i increased within 3 minutes after the
treatment of cultures with glutamate, and this peak
was followed by a plateau phase (Figure 6e). To con-
firm [Ca++]i increase is dependent on NMDA receptor,
similar experiments were performed using NMDA
instead of glutamate (Figure 6f). Overexpression of
ORP150 suppressed peak and plateau levels of intra-
cellular [Ca++]i after exposure to NMDA (neurons
from Tg PD-ORP150 mice), while decreased levels of
ORP150 (neurons from ORP150–/+ mice) were associ-
ated with higher levels of [Ca++]i (Figure 6, f–h). These
data suggest that ORP150 plays a pivotal role in the
defense mechanism against the perturbation of
[Ca++]i caused by the excitotoxicity.
It is known that a neutral protease calpain is activat-
ed by NMDA-induced calcium influx, and activated
calpain induces the cell death of neuron (27). To assess
the activation of calpain as one of the downstream
events following Ca++ influx, we performed an
immunoblotting analysis of cell extracts from gluta-
mate-treated cells with anti–µ-calpain Ab, which
demonstrated the presence of a more rapidly migrat-
ing band potentially consistent with the presence of
the autoactivated form of µ-calpain (Figure 7a) as well
as activation of the downstream enzyme cathepsin B
(Figure 7b). The more rapidly migrating µ-calpain
immunoreactive band was most evident in extracts of
neurons from ORP150–/+ mice, though the band was
also seen with samples from ORP150+/+ animals (Fig-
ure 7a, glutamate). In contrast, neurons from Tg PD-
ORP150 mice did not display the more rapidly migrat-
ing µ-calpain immunoreactive species (Figure 7a,
glutamate). Addition of a cell-permeable calpain
inhibitor, benzyloxycarbonyl-leucyl-leucyl-leucinal
(ZLLLal) (28), prevented appearance of the more rap-
idly migrating µ-calpain immunoreactive band in
extracts from ORP150+/+ mice and decreased intensity
of the band in samples from ORP150–/+ animals (Fig-
ure 7a, glutamate + ZLLLal). Similar results were
observed with respect to cathepsin B activity in
extracts of glutamate-treated neurons from mice with
different levels of ORP150 expression (Figure 7b). Glu-
tamate resulted in the most prominent rise in cathep-
sin B activity in neurons from ORP150–/+ mice, where-
as ORP150+/+ mice showed a diminished response, and
cells from Tg PD-ORP150 animals showed only about
2.5-fold increase in cathepsin B activity (Figure 7b, glu-
tamate). Addition of the aldehyde inhibitor for cal-
pain, ZLLLal, strongly suppressed cathepsin B activity
in each case (Figure 7d, glutamate + ZLLLal).
To confirm the role of ORP150 further in in vivo sit-
uations, protein extracts prepared from the hip-
pocampus after intrahippocampal administration of
kainate to mice were subjected to the immunoblot-
ting of µ-calpain. Consistent with the in vitro data,
the more rapidly migrating form of µ-calpain was
identified in extracts from kainate-treated ORP150–/+
and, to a lesser extent (only at the 0.4 µg/kg dose), in
samples from ORP+/+ mice, compared with its absence
at both kainate doses in samples from Tg PD-ORP150
mice (Figure 7c), and the same tendency was shown in
cathepsin B activity in samples from ORP150–/+ and
wild-type (ORP150+/+), compared with neurons from
Tg PD-ORP150 animals (Figure 7d).
Glutamate exerts neurotoxicity not only by increase
of [Ca++]i (Figure 6e), but also through the cysteine
depletion caused by the overload of glutamate-cys-
teine countertransport system in HT-22 (29) and
immature neuron cultures (22). To rule out the pos-
sibility that ORP150 is induced by cysteine depletion,
hippocampal neurons were exposed to a γ-glutamyl-
cysteine synthetase inhibitor, BSO, and protein
extracts were subjected to Western blot analysis using
anti–ORP150 IgG. Consistent with the previous
report (22), exposure of neurons to 1 mM BSO caused
depletion of cellular total GSH levels (by approxi-
mately 20% compared with vehicle-treated cultures
after 24 hours; data not shown). The levels of ORP150
remained low, compared with that subjected to
hypoxia (Figure 7e). Furthermore, neuron cultures
isolated from ORP–/+, nontransgenic littermate con-
trols (ORP150+/+), and Tg PD-ORP150 mice showed
similar vulnerability to BSO (up to 1 mM), suggesting
that Ca++ influx, rather then cysteine depletion, may
cause ORP150 and that expression of ORP150 is with-
out effect on the BSO-mediated cell death.
Discussion
These data indicate a close association of neuronal
stress induced by stimulation of glutamate receptors
and changes in ER physiology. Since ORP150 is an
inducible ER chaperone, glutamate-mediated cellular
perturbation appears to focus on the ER, leading to
increased [Ca++]i and, subsequently, activation of cal-
cium-dependent proteases. Such proteolytic events,
which have been shown to cause neuronal death (23,
27), are one representative of a series of downstream
reactions, though there is a possibility that this entire
phenomenon could be a secondary effect of induced
neuronal injury. Our data suggest ORP150, expressed
in response to glutamate stress, at least in this para-
digm, reduces neuronal injury and may thus play a
significant role in protecting neuronal cells as a con-
trolling mechanism responsible for glutamate-
induced elevation of [Ca++]i.
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The exact mechanism through which ORP150
exerts its protective effect(s), resulting in diminished
peak and plateau [Ca++]i, is unclear at present. In this
context, it is instructive to compare the properties of
ORP150 with those of glucose-regulated protein
GRP78, a 78-kDa ER chaperone first identified by its
induction due to glucose deprivation. A previous
study has demonstrated that GRP78 is also upregu-
lated in neurons by glutamate and that suppression
of GRP78 enhances neuronal vulnerability to gluta-
mate toxicity (30). The mechanism of GRP78-mediat-
ed neuroprotection appears to reside in its ability to
maintain Ca++ homeostasis, potentially (though not
necessarily) by a mechanism involving direct binding
of calcium to the chaperone (31). ORP150 is a homo-
logue of CPB140, 140-kDa calcium-binding protein
(32), identified as an ER protein with the capacity to
bind Ca++. Furthermore, since ORP150 has higher
affinity for ATP than other known polypeptide chap-
erones in the ER (33), its capacity to maintain Ca++
homeostasis may become especially relevant in the
face of limiting amounts of ATP. Such depletion of
high-energy phosphate compounds is associated with
glutamate stress (34, 35). Thus, we propose that
ORP150 and GRP78 may work in concert to protect
cells from glutamate toxicity. With more modest ener-
gy depletion, multiple ER chaperones potentially con-
tribute to the modulation of [Ca++]i, whereas when
ATP falls to low levels; only chaperones with high-
affinity for ATP, such as ORP150, have potent effects
on [Ca++]i and cytoprotective properties. Although
further experiments will be required to obtain direct
support for this hypothesis, the pivotal role of
ORP150 for modulating [Ca++]i and cell survival in
response to glutamate is clearly shown by our studies.
The observation that hippocampal expression of
GRP78 and GRP94 was unaffected in ORP150–/+ and
Tg PD-ORP150 mice (for example, glutamate caused
an increase in levels of GRP78&94), though gluta-
mate-induced [Ca++]i and neuronal cytotoxicity is
markedly changed, supports an important contribu-
tion of ORP150 to cellular homeostasis.
The relevance of ORP150 expression to the cellular
response to excitotoxic stress indicates the importance
of determining mechanisms triggering its production.
Since ORP150 induction is also observed in other set-
tings, such as hypoxia, it is possible that the mecha-
nism is indirect and involves ER cell stress pathways.
In this context, activation of NF-κB has been shown to
result from accumulation of polypeptides in the ER
(36). However, we have not observed NF-κB activation
in human cells where hypoxia-mediated ORP150
expression is suppressed (5). The unfolded protein
response is another mechanism through which gener-
al induction of cellular stress by glutamate might be
focused on the ER, resulting in enhanced expression
of ORP150. These considerations suggest a potential-
ly novel mechanism through which glutamate increas-
es neuronal levels of ORP150.
Addition of γ-glutamylcysteine synthetase inhibitor,
BSO, which depletes the cellular cysteine pool by
about 75% in primary neuron culture (22), failed to
induce ORP150, and overexpression of ORP150 did
not affect neuron viability, suggesting that cysteine
deprivation may cause stresses distinct from those tar-
geted to the ER. In this context, we have shown that
cell death caused by other stimuli, including hydrogen
peroxide, staurosporine, and nitric oxide was not pre-
vented by the overexpression of ORP150 (5, 15).
Taken together, our data demonstrate that the
expression of the ER chaperone ORP150 has critical
cytoprotective properties, probably as a consequence
of its capacity to regulate [Ca++]i, thereby linking glu-
tamate-receptor stimulation to activation of down-
stream calcium-dependent proteases mediating cell
death. Though other indirect mechanisms involving
modulation of cytoplasmic Ca++ buffering and alter-
ations in calcium influx via the NMDA receptor
remain possible, these data at least suggest the possi-
ble future relevance of therapeutic strategies targeting
the ER and potentially upregulating ORP150 to rescue
neurons from excitotoxicity.
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